BioSpace News Archive

Organs-on-chips Market Growth and Restrain Factors Analysis

Organs-on-chips or organ-on-a-chip is an electronic gadget that consists of a 3D microfluidic cell culture-based multi-channel structure.

March 24, 2020
·
5 min read
Heparin Market to Gain a Revenue Worth US$16.3 Billion by 2024

The global heparin market is anticipated to attract growth opportunities on the back of the rising count of surgical procedures and increasing treatment of venous thromboembolism including pulmonary embolism and deep vein thrombosis.

March 24, 2020
·
4 min read
Drug Development

Novavax Shares Spike After Successful Late-Stage NanoFlu Vaccine Trial

The primary objectives were non-inferior immunogenicity of NanoFlu compared to Sanofi’s Fluzone Quadrivalent based on several 28-day metrics.

March 24, 2020
·
2 min read
·
Mark Terry
High-resolution Melting Analysis Market – Latest Trends and Future Aspect Analysis to 2025

High resolution melting analysis is a powerful and strong methodology in molecular biology for the purpose of detecting epigenetic differences, polymorphisms, and mutations in double-stranded DNA samples.

March 24, 2020
·
4 min read
Intravenous Immunoglobulin (IVIG) Market: Rise in Prevalence of Autoimmune Disorders to Drive Market

Intravenous immunoglobulin, or IVIG, is essentially a plasma product.

March 24, 2020
·
4 min read
Non-opioid Pain Treatment Market Competitive Landscape Analysis With Forecast by 2027

Evidences show that non-opioid medications and non-pharmacologic interventions can be effective in treating common types of chronic pain and are considered safer than opioids

March 24, 2020
·
5 min read
Business

Astellas and CytomX Strike Immuno-Oncology Deal Worth More than $1.6 Billion

Under terms of the agreement, Astellas will make an upfront cash payment of $80 million to CytomX.

March 24, 2020
·
2 min read
·
Alex Keown
FDA

Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa

The ointment had previously been approved for patients ages two and above in 2016.

March 24, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Industry News for March 24: Update on the Novel Coronavirus

A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.

March 24, 2020
·
4 min read
·
BioSpace Editorial Staff
Business

Roche CEO: Broad Testing for COVID-19 Could Take “Weeks, If Not Months”

“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”

March 24, 2020
·
4 min read
·
Mark Terry